Biopsy and Mutation Detection Strategies in Non-Small Cell Lung Cancer

The emergence of new therapeutic agents for non-small cell lung cancer (NSCLC) implies that histologic subtyping and molecular predictive testing are now essential for therapeutic decisions. Histologic subtype predicts the efficacy and toxicity of some treatment agents, as do genetic alterations, wh...

Descripción completa

Detalles Bibliográficos
Autor principal: Jung, Chi Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861373/
https://www.ncbi.nlm.nih.gov/pubmed/24348665
http://dx.doi.org/10.4046/trd.2013.75.5.181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861373/
https://www.ncbi.nlm.nih.gov/pubmed/24348665
http://dx.doi.org/10.4046/trd.2013.75.5.181

Ejemplares similares